Live feed
Filing
SC 13D/A
SC 13D/A0001104659-24-014719·Mineralys Therapeutics, Inc.
Schedule 13D ownership disclosure
Mineralys Therapeutics Inc
Security class unavailable · CUSIP: 603170101
Event date: 2024-02-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,074,916
- Percent of class
- 10.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-014719
- Form type
- SC 13D/A
- Filer
- Mineralys Therapeutics, Inc.
- CIK
- CIK 1933414
- Filed
- Feb 12, 2024
- Reporting period
- Feb 12, 2024
- Description
- Schedule 13D beneficial ownership